NC
NEUMANN CLARKE Other
US US · SEC (Form 4)
Discover the detailed record of transactions filed by NEUMANN CLARKE. Insider active across 3 companies, notably Progenity, INC.. In total, 9 disclosures have been recorded. The latest transaction was disclosed on 15 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations 9 total
€5,989 8,305 shares @ €0.7211 0.0000% mcap 100.0% of flow
Common Stock
SEC:0000899243-22-018432:0 · 15 May 2022
0184,843 shares 0
Common Stock
SEC:0000899243-22-015060:0 · 15 Apr 2022
€2,884 1,716 shares @ €1.6805 14.5% of flow
Common Stock
SEC:0000899243-22-006783:0 · 15 Feb 2022
€2,281 752 shares @ €3.0328 26.8% of flow
Common Stock
SEC:0000899243-21-045047 · 15 Nov 2021
€2,281 752 shares @ €3.0328 11.5% of flow
Common Stock
SEC:0000899243-21-045047:0 · 15 Nov 2021
€3,288 2,336 shares @ €1.4074 38.6% of flow
Common Stock
SEC:0000899243-21-033256 · 15 Aug 2021
€3,288 2,336 shares @ €1.4074 16.5% of flow
Common Stock
SEC:0000899243-21-033256:0 · 15 Aug 2021
€2,941 1,505 shares @ €1.9541 34.6% of flow
Common Stock
SEC:0000899243-21-019674 · 15 May 2021
€2,941 1,505 shares @ €1.9541 14.8% of flow
Common Stock
SEC:0000899243-21-019674:0 · 15 May 2021
About NEUMANN CLARKE Clarke Neumann is a director at Progenity, Inc. and Biora Therapeutics, Inc.